nad has been researched along with Nerve Degeneration in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (15.38) | 18.7374 |
1990's | 2 (5.13) | 18.2507 |
2000's | 9 (23.08) | 29.6817 |
2010's | 16 (41.03) | 24.3611 |
2020's | 6 (15.38) | 2.80 |
Authors | Studies |
---|---|
Bressac, L; Guerreiro, S; Privat, AL; Toulorge, D | 1 |
Brenner, C; Hatano, M; Hattori, T; Higashida, H; Hori, O; Ito, M; Noda, M; Okamoto, H; Roboon, J; Sugimoto, H; Takaso, Y; Yamamoto, Y; Yoshizaki, T | 1 |
Alandes, S; Alcácer, J; Banacloche, S; Benlloch, M; Colomer, N; Coronado, JA; Drehmer, E; Estrela, JM; Jihad-Jebbar, A; López-Blanch, R; Marchio, P; Obrador, E; Rivera, P; Salvador, R; Vallés, SL | 1 |
Tong, L | 1 |
Brenner, C; Hattori, T; Heer, CD; Higashida, H; Hori, O; Ishii, H; Nguyen, DT; O'Meally, D; Okamoto, H; Roboon, J; Takarada-Iemata, M; Yamamoto, Y | 1 |
Celardo, I; Fedele, G; Loh, SHY; Martins, LM; Yu, Y | 1 |
DiAntonio, A; Essuman, K; Mao, X; Milbrandt, J; Sasaki, Y; Summers, DW | 1 |
Brenner, C; Cambronne, XA; Cohen, MS; Goodman, RH; Liu, HW; Migaud, ME; Schmidt, MS; Smith, CB | 1 |
Gong, YL; Hou, YF; Huang, GR; Li, ST; Liu, JM; Shan, C; Sun, LH; Tao, B; Wang, SM; Zhao, HY; Zhu, Q; Zhuang, QQ | 1 |
Ding, D; Roth, JA; Salvi, R; Wang, L | 1 |
Bros, H; Infante-Duarte, C; Millward, JM; Niesner, R; Paul, F | 1 |
Aschner, M; Caito, SW | 1 |
Ding, ZX; Guo, WH; Hao, J; Hu, YL; Li, GB; Li, HY; Qi, XX; Sun, JH; Wu, Q; Zhang, J | 1 |
Bramley, JC; Buchser, WJ; Clark, KB; Collins, SV | 1 |
DiAntonio, A; Mao, X; Milbrandt, J; Nakagawa, T; Sasaki, Y | 1 |
Chen, J; Gao, Y; Li, W; Signore, AP; Stetler, RA; Vosler, PS; Wang, S; Xing, Z; Yin, H; Zhang, F | 1 |
Lund, FE; Milbrandt, J; Sasaki, Y; Vohra, BP | 1 |
Tang, BL | 1 |
Garakani, A; Miller, T; Romero, P | 1 |
Alano, CC; Garnier, P; Higashi, Y; Kauppinen, TM; Swanson, RA; Ying, W | 1 |
Arama, E; Assa-Kunik, E; Haklai-Topper, L; Minis, A; Schoenmann, Z; Tiomny, S; Yaron, A | 1 |
Feng, Y; He, Z; Yan, T; Zhai, Q | 1 |
Choi, WS; Palmiter, RD; Xia, Z | 1 |
Choi, BY; Sohn, M; Suh, SW; Swanson, RA; Won, SJ; Ying, W; Yoo, BH | 1 |
Giaume, C; Orellana, JA; Sáez, JC; von Bernhardi, R | 1 |
Danielson, SK; Jaradeh, SS; Kulpa, JI; Rhee, JS; Schulze, SL; Toohill, RJ | 1 |
Akhter, W; Ashraf, QM; Delivoria-Papadopoulos, M; Mishra, OP | 1 |
Hu, S; Peterson, PK; Shideman, CR; Thayer, SA | 1 |
Araki, T; Milbrandt, J; Sasaki, Y | 1 |
Chitnis, T; He, Z; Hurrell, JM; Kaneko, M; Kaneko, S; Khoury, SJ; Wang, J; Yiu, G | 1 |
Bellen, HJ; Cao, Y; Hiesinger, PR; Mehta, SQ; Schulze, KL; Verstreken, P; Zhai, RG; Zhou, Y | 1 |
Adams, JD; Hutchin, TP; Klaidman, LK; Mukherjee, SK | 1 |
Ben-Bassat, S; Duvdevani, R; Lavie, V; Schwartz, M; Yoles, E; Zalish, M | 1 |
Meyer, U; Wenk, H | 1 |
Jacobson, S; Koenig, H; Ross, E | 1 |
Faro, MD | 1 |
Feret, J; Sokolowska-Pituchowa, J; Wohn, A | 1 |
Cognazzo, A; Martin, L | 1 |
Friede, RL; Martinez, AJ | 1 |
3 review(s) available for nad and Nerve Degeneration
Article | Year |
---|---|
CD38 in Neurodegeneration and Neuroinflammation.
Topics: ADP-ribosyl Cyclase 1; Aging; Animals; Astrocytes; Brain; Humans; Membrane Glycoproteins; Mice; Mice, Knockout; Microglia; NAD; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents | 2020 |
Wld(S), Nmnats and axon degeneration--progress in the past two decades.
Topics: Animals; Axons; Humans; Mice; Mice, Mutant Strains; Models, Neurological; Mutant Proteins; Mutation; NAD; Nerve Degeneration; Nerve Tissue Proteins; Nicotinamide-Nucleotide Adenylyltransferase | 2010 |
Glial hemichannels and their involvement in aging and neurodegenerative diseases.
Topics: Adenosine Triphosphate; Aging; Astrocytes; Calcium; Cannabinoids; Central Nervous System; Connexin 43; Connexins; Dinoprostone; Glucose; Glutamic Acid; Humans; Inflammation; Interleukin-1beta; Ion Channels; NAD; Nerve Degeneration; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Oligodendroglia; Signal Transduction; Tumor Necrosis Factor-alpha | 2012 |
36 other study(ies) available for nad and Nerve Degeneration
Article | Year |
---|---|
Deletion of CD38 and supplementation of NAD
Topics: ADP-ribosyl Cyclase 1; Animals; Axons; Axotomy; Cell Count; Cells, Cultured; Dietary Supplements; Disease Models, Animal; Facial Nerve; Facial Nerve Diseases; Humans; Mice; Mice, Inbred ICR; Mice, Knockout; NAD; Nerve Degeneration | 2020 |
Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Apoptosis; Cytokines; Female; Male; Metabolome; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Motor Activity; Motor Neurons; Mutation; NAD; Nerve Degeneration; NF-E2-Related Factor 2; Niacinamide; Oxidation-Reduction; Pyridinium Compounds; Reactive Oxygen Species; Sirtuin 1; Sirtuin 3; Spinal Cord; Stilbenes; Superoxide Dismutase-1; Survival Analysis | 2021 |
How to diSARM the executioner of axon degeneration.
Topics: Animals; Armadillo Domain Proteins; Axons; Cytoskeletal Proteins; Humans; NAD; NAD+ Nucleosidase; Nerve Degeneration; Protein Domains | 2021 |
Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD
Topics: ADP-ribosyl Cyclase 1; Animals; Apigenin; Astrocytes; Chemokines; Cytokines; Gene Deletion; Hippocampus; Inflammation; Injections, Intraventricular; Lipopolysaccharides; Macrophage Activation; Male; Membrane Glycoproteins; Mice; Mice, Inbred ICR; Mice, Knockout; Microglia; NAD; Nerve Degeneration; NF-kappa B; Niacinamide; Pyridinium Compounds | 2021 |
Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Behavior, Animal; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Humans; Metabolome; Metabolomics; Mitochondria; Motor Activity; Mutation; NAD; Nerve Degeneration; Neurons; Niacinamide; Poly (ADP-Ribose) Polymerase-1; Polymorphism, Single Nucleotide | 2021 |
The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD
Topics: Animals; Armadillo Domain Proteins; Axons; Catalytic Domain; Cells, Cultured; Cytoskeletal Proteins; Humans; Mice; Mice, Knockout; NAD; NAD+ Nucleosidase; Nerve Degeneration | 2017 |
Pharmacological bypass of NAD
Topics: Acrylamides; Animals; Antineoplastic Agents, Phytogenic; Drug Combinations; Francisella tularensis; Ganglia, Spinal; NAD; Nerve Degeneration; Neurons; Niacinamide; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Piperidines; Pyridinium Compounds; Vincristine | 2018 |
Protective effects of β- nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson's disease.
Topics: Animals; Cell Survival; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Humans; Male; Mice; Microinjections; Mitochondria; Motor Activity; NAD; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary | 2019 |
Nicotinamide adenine dinucleotide prevents neuroaxonal degeneration induced by manganese in cochlear organotypic cultures.
Topics: Animals; Cochlea; Cochlear Nerve; Manganese; NAD; Nerve Degeneration; Neuroprotective Agents; Organ Culture Techniques; Rats; Rats, Sprague-Dawley | 2014 |
Oxidative damage to mitochondria at the nodes of Ranvier precedes axon degeneration in ex vivo transected axons.
Topics: Animals; Axons; Energy Metabolism; Female; Hydrogen Peroxide; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Mitochondria; NAD; Nerve Degeneration; Oxidation-Reduction; Oxidative Stress; Pyruvates; Ranvier's Nodes; Rhizotomy; Spinal Nerve Roots; Statistics, Nonparametric | 2014 |
NAD+ Supplementation Attenuates Methylmercury Dopaminergic and Mitochondrial Toxicity in Caenorhabditis Elegans.
Topics: Animals; Animals, Genetically Modified; Behavior, Animal; Caenorhabditis elegans; Cytoprotection; Dopaminergic Neurons; Dose-Response Relationship, Drug; Genotype; Methylmercury Compounds; Mitochondria; Mutation; NAD; Nerve Degeneration; Oxidation-Reduction; Oxidative Stress; Phenotype | 2016 |
Roles of NAD in Protection of Axon against Degeneration via SIRT1 Pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Axons; Cell Count; Ganglia, Spinal; NAD; Nerve Degeneration; Neurites; Neuroprotective Agents; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Sirtuin 1; Vincristine | 2016 |
Avian axons undergo Wallerian degeneration after injury and stress.
Topics: Analysis of Variance; Animals; Axons; Axotomy; Calcium; Cells, Cultured; Disease Models, Animal; Finches; Microscopy, Confocal; Microscopy, Fluorescence; NAD; Nerve Degeneration; Paclitaxel; Pressure; Retinal Ganglion Cells; Stress, Physiological; Vincristine; Wallerian Degeneration | 2016 |
NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Topics: Animals; Armadillo Domain Proteins; Axons; Cytoskeletal Proteins; Ganglia, Spinal; Mice; NAD; Nerve Degeneration; Nicotinamide-Nucleotide Adenylyltransferase | 2016 |
Cellular NAD replenishment confers marked neuroprotection against ischemic cell death: role of enhanced DNA repair.
Topics: Animals; Brain Ischemia; Cell Death; Cell Survival; Cells, Cultured; Cytoprotection; DNA Polymerase beta; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Dose-Response Relationship, Drug; NAD; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Rats; Signal Transduction | 2008 |
Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide.
Topics: Animals; Axons; Cell Line; Drosophila melanogaster; Enzyme Activation; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NAD; Nerve Degeneration; Neurons; Nicotinamide-Nucleotide Adenylyltransferase | 2009 |
Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis.
Topics: AMP-Activated Protein Kinases; Animals; Brain; Cell Death; Models, Neurological; NAD; Nerve Degeneration; Neurons; Neuroprotective Agents; Resveratrol; Sirtuin 1; Spinal Cord; Stilbenes | 2010 |
A neurite quality index and machine vision software for improved quantification of neurodegeneration.
Topics: Cells, Cultured; Ganglia, Spinal; Humans; Image Processing, Computer-Assisted; NAD; Nerve Degeneration; Neurites; Software | 2009 |
NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death.
Topics: Animals; Apoptosis Inducing Factor; Cell Death; Cell Respiration; Cells, Cultured; Energy Metabolism; Glycolysis; Mice; Mice, Knockout; Mitochondria; Mitochondrial Diseases; NAD; Nerve Degeneration; Neurons; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Transport; Receptors, Purinergic P2; Receptors, Purinergic P2X7 | 2010 |
Axonal degeneration is regulated by the apoptotic machinery or a NAD+-sensitive pathway in insects and mammals.
Topics: Animals; Apoptosis Regulatory Proteins; Axons; bcl-2-Associated X Protein; Caspase 3; Caspase 6; Caspase Inhibitors; Caspases; Cells, Cultured; Dendrites; Drosophila; Drosophila Proteins; Enzyme Inhibitors; Ganglia, Spinal; Mice; Mice, Knockout; Mice, Transgenic; NAD; Nerve Degeneration; Nerve Tissue Proteins; Sensory Receptor Cells; Signal Transduction | 2010 |
Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cytoplasm; Disease Models, Animal; Dopamine; Electron Transport Complex I; Mice; Microtubules; NAD; Nerve Degeneration; Parkinson Disease; Reactive Oxygen Species; Rotenone; Substantia Nigra; Vesicular Monoamine Transport Proteins | 2011 |
Prevention of traumatic brain injury-induced neuron death by intranasal delivery of nicotinamide adenine dinucleotide.
Topics: Administration, Intranasal; Animals; Brain Damage, Chronic; Brain Injuries; Cell Death; Male; Microglia; NAD; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2012 |
Morphology of the cricopharyngeal muscle in Zenker and control specimens.
Topics: Adenosine Triphosphatases; Adult; Aged; Aged, 80 and over; Atrophy; Biopsy; Esophagus; Female; Humans; Laryngeal Nerves; Male; Middle Aged; Muscle Fibers, Skeletal; NAD; Nerve Degeneration; Pharyngeal Muscles; Vagus Nerve; Zenker Diverticulum | 2002 |
Hypoxia-induced modification of poly (ADP-ribose) polymerase and dna polymerase beta activity in cerebral cortical nuclei of newborn piglets: role of nitric oxide.
Topics: Adenosine Triphosphate; Animals; Asphyxia Neonatorum; Cell Nucleus; Cerebral Cortex; DNA Damage; DNA Polymerase beta; DNA Repair; Enzyme Inhibitors; Humans; Hypoxia, Brain; Infant, Newborn; NAD; Nerve Degeneration; Neurons; Nitric Oxide; Nitroarginine; Phosphocreatine; Poly(ADP-ribose) Polymerases; Recovery of Function; Sus scrofa; Up-Regulation | 2003 |
CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism.
Topics: Agammaglobulinaemia Tyrosine Kinase; Calcium; Calcium Channels; Calcium Signaling; Cells, Cultured; Chemokine CCL5; Chemokines, CC; Cyclic ADP-Ribose; Encephalitis; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Immunity, Innate; Immunologic Surveillance; Inositol 1,4,5-Trisphosphate; Janus Kinase 1; Microglia; NAD; Nerve Degeneration; Phosphatidylinositol 3-Kinases; Protein-Tyrosine Kinases; Receptors, CCR5; Signal Transduction; Type C Phospholipases | 2006 |
Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy.
Topics: Animals; Axons; Axotomy; Cell Line; Denervation; Enzyme Precursors; Enzymes; Ganglia, Spinal; Humans; Male; NAD; Nerve Degeneration; Neurons; Nicotinamide-Nucleotide Adenylyltransferase; Postoperative Period; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Time Factors | 2006 |
Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models.
Topics: Animals; Axons; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Multiple Sclerosis; NAD; Nerve Degeneration; Neuroprotective Agents; Rats; Wallerian Degeneration | 2006 |
Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity.
Topics: Animals; Animals, Genetically Modified; Disease Models, Animal; Drosophila; Mice; Mutant Proteins; NAD; Nerve Degeneration; Neurons; Nicotinamide-Nucleotide Adenylyltransferase; Retina; Wallerian Degeneration | 2006 |
Nicotinamide as a precursor for NAD+ prevents apoptosis in the mouse brain induced by tertiary-butylhydroperoxide.
Topics: Animals; Apoptosis; Brain; DNA; DNA Repair; Immunohistochemistry; Injections, Intraventricular; Mice; Mice, Inbred C57BL; NAD; Nerve Degeneration; Niacinamide; Oxidative Stress; Peroxides; Poly(ADP-ribose) Polymerases; tert-Butylhydroperoxide | 1996 |
GM1 reduces injury-induced metabolic deficits and degeneration in the rat optic nerve.
Topics: Animals; Axons; Cell Count; Cell Survival; Disease Models, Animal; G(M1) Ganglioside; Injections, Intraperitoneal; Male; NAD; Nerve Degeneration; Optic Nerve; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence | 1992 |
[Oxidoreductase activity in long term cultures of dissociated trigeminal ganglia cells of the chick embryo].
Topics: Animals; Cells, Cultured; Chick Embryo; Collagen; Culture Media; Cytoplasm; Glucosephosphate Dehydrogenase; Glycerolphosphate Dehydrogenase; Histocytochemistry; Hydroxybutyrate Dehydrogenase; L-Lactate Dehydrogenase; Microscopy, Phase-Contrast; NAD; NADP; Nerve Degeneration; Nerve Growth Factors; Neurons; Oxidoreductases; Succinate Dehydrogenase; Tetrazolium Salts; Time Factors; Trigeminal Nerve | 1973 |
Cytochemical and electron microscopic study of a case of Jakob-Creutzfeldt disease.
Topics: Acid Phosphatase; Aphasia; Brain; Central Nervous System Diseases; Cerebral Cortex; Dementia; Deoxyribonucleases; Dihydrolipoamide Dehydrogenase; Frontal Lobe; Histocytochemistry; Humans; Lysosomes; Male; Microscopy, Electron; Middle Aged; Motor Neurons; NAD; Nerve Degeneration; Neuroglia; Oxidoreductases; Pigments, Biological; RNA; Spinal Cord | 1967 |
Lactic dehydrogenase activity in neuron-free spinal cord tissue obtained by a new method.
Topics: Animals; Cats; Cellulose; Cerebral Cortex; Chromatography; Electrophoresis; Histological Techniques; Ions; Kinetics; L-Lactate Dehydrogenase; Methods; NAD; Nerve Degeneration; Neuroglia; Spinal Cord | 1968 |
[Behavior of the diaphorase of coenzyme I (NAD) during degeneration of the sciatic nerve in hooded rats after nerve freezing].
Topics: Animals; Dihydrolipoamide Dehydrogenase; Freezing; NAD; Nerve Degeneration; Rats; Sciatic Nerve | 1969 |
A sporadic case of juvenile amyotrophic lateral sclerosis; semi-quantitative and histo-enzymatical study of the denervated muscles.
Topics: Adenosine Triphosphatases; Adult; Age Factors; Amyotrophic Lateral Sclerosis; Autopsy; Edetic Acid; Female; Histocytochemistry; Humans; Muscles; NAD; Nerve Degeneration; Oxidoreductases; Pons; Pyramidal Tracts; Spinal Cord; Tetrazolium Salts | 1970 |
Analysis of axon-sheath relations during early Wallerian degeneration.
Topics: Animals; Axons; Dihydrolipoamide Dehydrogenase; Histocytochemistry; Microscopy, Electron; Mitochondria; Myelin Sheath; NAD; Nerve Degeneration; Nerve Fibers, Myelinated; Rats; Schwann Cells; Sciatic Nerve | 1970 |